BIRC5 and colorectal cancer: As it is believed that overexpression of survivin in cancer stem-like cells lead to the failure of clinical drug administration, prodigiosebne could be a good choice for fighting against this obstacle in counties with high morbidity and mortality of colorectal cancer, such as Iran [35].